Cancer functions as an evolutionary process within the body
Multiple genomic and molecular studies demonstrate that cancer develops, diversifies, and adapts through processes of clonal evolution and natural selection within the body.
The claim states that cancer functions as an evolutionary process within the body. All provided papers discuss tumor heterogeneity, clonal evolution, and evolutionary pathways in various cancers (lung cancer, retinoblastoma, and pan-cancer analyses), directly supporting the claim. Therefore, the verdict is SUPPORTED.
Ugo Testa, Germana Castelli, Elvira Pelosi. Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells. 2018. https://doi.org/10.3390/cancers10080248
This study discusses clonal heterogeneity and evolution in lung cancer, demonstrating how sub-clones and clonal evolution drive tumor progression and drug resistance.
See more details
Clément Hua. Multi-omic analyses to characterize retinoblastoma heterogeneity and clonal evolution. https://doi.org/10.70675/317c0f7azf042z488eza0ddz1ec00ba2ac96
This study analyzes retinoblastoma heterogeneity and reconstructs clonal evolution, showing how distinct tumor sub-populations accumulate alterations through evolutionary progression models.
Ksenia Sokolova, Vessela N. Kristensen, Olga G. Troyanskaya. Abstract 1295: Deep-learning profiling of regulatory somatic variants across clonal cancer evolution.. 2026. https://doi.org/10.1158/1538-7445.am2026-1295
This study investigates clonal cancer evolution and regulatory somatic variants, utilizing evolution-aware annotations to understand tumor progression and patient outcomes.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt